Today, Jazz Pharmaceuticals, Inc. declared that the U.S. Food and Drug Administration has authorised Once-A-Day LUVOX CR Extended-Release Capsules for the communication of ethnic anxiousness modify and psychoneurotic ambitious modify in adults.